Replies to post #5008 on Soligenix Inc (SNGX)

[Ebuilder]

I think they heard you........Lets Roll!!!!

[ash111]

Soligenix Announces Collaboration with the National Organization for Rare Disorders and the Cutaneous Lymphoma Foundation in Advancing its Phase 3 Study of SGX301 for the Treatment of Cutaneous T-Cell Lymphomahttp://www.soligenix.com/news.aspx?titleId=487